<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "riociguat tab">
<dose><value>0.5</value>
<value>1</value>
<value>1.5</value>
<value>2</value>
<value>2.5</value>
</dose>
<route><value>PO</value>
</route>
<strength><value>0.5 mg</value>
<value>1 mg</value>
<value>1.5 mg</value>
<value>2 mg</value>
<value>2.5 mg</value>
</strength>
<frequency><value>TID</value>
</frequency>
<instruction></instruction>
<volume></volume>
<units><value>mg</value>
</units>
<Population></Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Increased risk of mortality and serious adverse effects in patients with Pulmonary Hypertension associated with Idiopathic Interstitial Pneumonias. [Health Canada August 15, 2016]</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=8681</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=8682</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=8683</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=8684</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=8685</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary with Restrictions.</value>
</AHSFormularyStatus>
<AHFSName><value>Vasodilating Agents</value>
</AHFSName>
<HighAlert></HighAlert>
</drug>